Skip to content

Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus.

Jerrold C Winter, R A Rabin

Pharmacology, Biochemistry, and Behavior July 1988 DOI: 10.1016/0091-3057(88)90074-3 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Animal drug discrimination study Peer reviewed
Population Rats trained to discriminate 0.1 mg LSD from saline
Interventions LSD 5-methoxy-dimethyltryptamine (MDMT) 2 5-dimethoxy-4-methyl-amphetamine (DOM) 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) m-trifluoromethylphenyl-piperazine (TFMPP) 5-methoxy-3-(1 3 6-tetrahydro-4-pyridinyl)-1H-indole (RU-24969) pizotyline pirenperone
Dose 0.1 mg LSD
Topics LSD Serotonin
Key points DOM fully substituted for the LSD cue, and pizotyline and pirenperone blocked both DOM and LSD, whereas MDMT, 8-OH-DPAT, TFMPP, and RU-24969 substituted only partially and were variably affected by the antagonists. Unexpectedly, pizotyline and pirenperone potentiated the stimulus or disruptive effects of certain doses of 8-OH-DPAT and TFMPP, which the authors suggest indicates more complex drug interactions than previously assumed.

Abstract

Drugs purported to have selective affinities for 5-HT1A, 5-HT1B, and 5-HT2 receptors were tested in rats trained with 0.1 mg LSD versus saline. Included were 5-methoxy-dimethyltryptamine (MDMT), 2,5-dimethoxy-4-methyl-amphetamine (DOM), 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), m-trifluoromethylphenyl-piperazine (TFMPP), and 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole (RU-24969). Tests were then repeated in the presence of either pizotyline or pirenperone. DOM substituted for LSD and both were blocked by pizotyline and pirenperone. MDMT, 8-OH-DPAT, TFMPP, and RU-24969 substituted less completely and were variably affected by the antagonists. An unexpected result was potentiation of the stimulus or disruptive effects of certain doses of 8-OH-DPAT and TFMPP by pizotyline and pirenperone. The present findings suggest more complex interactions between these drugs than has previously been assumed.

Comparable studies

Other preclinical and animal studies on LSD, most cited first.

Study Year Design Participants
Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex Human embryonic kidney 293 cells stably expressing 5-HT2ARs; wild-type and 5-HT2AR... 2003 Experimental study
Evidence for a central 5‐hydroxytryptamine receptor stimulation by lysergic acid diethylamide Rats 1968 Experimental study
Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression Rats 2020 Preclinical study
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission Male mice 2021 Multidisciplinary experimental study with in vivo electrophysiology, optogenetics, behavioral paradigms, molecular biology, and conditional knockout mice
A non-hallucinogenic LSD analog with therapeutic potential for mood disorders. Mice and cultured rat cortical neurons 2023 Preclinical study

Citations in the library

Explore topics